EX-16.1 2 f8k030216ex16i_immucellcorp.htm LETTER FROM BAKER NEWMAN & NOYES, LLC

Exhibit 16.1

 

March 7, 2016

 

 

Securities and Exchange Commission

Washington, D.C. 20549

 

Commissioners:

 

We have read ImmuCell Corporation’s statements included under Item 4.01 of its Form 8-K filed on March 7, 2016 and we agree with such statements concerning our firm.

 

 

/s/ Baker Newman & Noyes

 

BAKER NEWMAN & NOYES

LIMITED LIABILITY COMPANY